PYXS Pyxis Oncology
- 1.900
- -0.200-9.52%
- 1.890
- -0.010-0.52%
Pyxis Oncology所有資訊
Pyxis Oncology | SC 13G/A：超過5%持股股東披露文件(修正)-Laurion Capital Management LP(6.15%),Benjamin Alexander Smith(6.15%)等
Pyxis Oncology | SC 13G/A：超過5%持股股東披露文件(修正)-Bayer World Investments B.V.(4.7%),Bayer Aktiengesellschaft(4.7%)
Pyxis Oncology | 4：持股變動聲明-董事 Metzger Michael A
Pyxis Oncology | 3：首次持股聲明-董事 Metzger Michael A
Pyxis Oncology | 4：持股變動聲明-董事 Palani Santhosh
Pyxis Oncology | SC 13D/A：超過5%持股股東披露文件(修正)-Lara Sullivan(8.89%)
Pyxis Oncology | 4：持股變動聲明-高管 Sullivan Lara
Pyxis Oncology | 4：持股變動聲明-董事 FLAVIN JOHN L
Pyxis Oncology | 4：持股變動聲明-董事 Civik Thomas
Pyxis Oncology | 4：持股變動聲明-董事 HUMPHREY RACHEL
Pyxis Oncology | 4：持股變動聲明-高管 Connealy Pamela Ann
Pyxis Oncology | 4：持股變動聲明-董事 Cline Darren S
Pyxis Oncology | 4：持股變動聲明-董事 Lewis-Hall Freda C
Pyxis Oncology | 4：持股變動聲明-董事 Dupont Jakob
Pyxis Oncology | 4：持股變動聲明-高管 Wadhane Jitendra
Pyxis Oncology | 4：持股變動聲明-董事 Palani Santhosh
Pyxis Oncology | 3：首次持股聲明-董事 Palani Santhosh
Pyxis Oncology | SC 13G：超過5%持股股東披露文件-Deep Track Capital, LP(7.87%),Deep Track Biotechnology Master Fund, Ltd.(7.87%)等
Pyxis Oncology | SC 13G/A：超過5%持股股東披露文件(修正)-TANG CAPITAL PARTNERS, LP(0.0%),Tang Capital Management, LLC(0.0%)等
Pyxis Oncology | SC 13G/A：超過5%持股股東披露文件(修正)-Biotechnology Value Fund, L.P.(0%),BVF I GP LLC(0%)等
分析
目標價預測
暫無數據
暫無數據